TABLE 1.
Demographic, clinical and laboratory data from patients with spontaneous bacterial peritonitis (SBP) and controls
| SBP | P* | ||
|---|---|---|---|
|
| |||
| Yes (n=51) | No (n=102) | ||
| Age, years | 60.2 (55.5–69.7) | 61.1 (52.0–68.1) | 0.72 |
| Male sex | 41 (80) | 73 (72) | 0.238 |
| Race | 0.334 | ||
| Caucasian | 48 (94) | 100 (98) | |
| Other | 3 (6) | 2 (2) | |
| History of hepatic encephalopathy | 23 (45) | 44 (43) | 0.818 |
| History of esophageal varices | 35 (69) | 62 (61) | 0.342 |
| Serum bilirubin at admission, μmol/L | 66 (47–196) | 72 (49–115) | 0.595 |
| Serum creatinine at admission, μmol/L | 98 (70–133) | 100 (66–124) | 0.392 |
| Serum sodium at admission, mmol/L | 133 (129–136) n=34 |
134 (129–136) n=58 |
0.668 |
| Ascites protein, g/L | 12 (5–20) | 8.5 (5–14) | 0.238 |
| Etiology of cirrhosis | 0.491 | ||
| Alcohol | 25 (49) | 44 (43) | |
| HCV/HBV | 14 (28) | 27 (27) | |
| NASH/cryptogenic | 8 (16) | 26 (26) | |
| Other | 4 (8) | 5 (5) | |
| Diabetes mellitus | 16 (31) | 33 (32) | 0.903 |
| Child-Pugh score | 11 (10–12) | 10 (10–11) | 0.352 |
| MELD score | 21 (17–27) | 20 (16–23) | 0.112 |
| PPI use | 31 (61) | 43 (42) | 0.03 |
Data presented as median (quartile 1-quartile 3) or n (%) unless otherwise indicated.
*
P<0.05 considered to be statistically significant. HBV Hepatitis B virus; HCV Hepatitis C virus; MELD Model for End-stage Liver Disease; NASH Nonalcoholic steatohepatitis; PPI Proton pump inhibitor